Detection of TR 34 /L98H CYP51A Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017
Author(s) -
Elizabeth L. Berkow,
Natalie S. Nunnally,
Alex Bandea,
R J Kuykendall,
Karlyn D. Beer,
Shawn R. Lockhart
Publication year - 2018
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02240-17
Subject(s) - aspergillus fumigatus , broth microdilution , azole , microbiology and biotechnology , biology , benzimidazole , aspergillus , population , mutation , chemistry , gene , minimum inhibitory concentration , antifungal , antibiotics , genetics , medicine , organic chemistry , environmental health
The emergence of azole-resistantAspergillus fumigatus has become a clinical problem in many parts of the world. Several amino acid mutations in the azole target protein Cyp51Ap contribute to this resistance, with the most concerning being the environmentally derived TR34 /L98H and TR46 /Y121F/T289A mutations. Here, we performed passive surveillance to assess a sample of theA. fumigatus population in the United States for the presence of these mutations. We found 1.4% of those isolates to exhibit elevated MIC via broth microdilution, and five of those isolates harbored the TR34 /L98H mutation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom